Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.FDA Philippines has issued a certificate of product registration (CPR) to Inergetics, a developer of nutritional supplements for the clinical health and sports supplement markets, to market Resurgex Select product as a nutritional supplement for cancer patients and other immune-compromised individuals throughout the country.
Subscribe to our email newsletter
New Marketlink Pharmaceutical Corporation, a distributor of pharmaceutical and healthcare products in the Philippines and Inergetics’ marketing and distribution partner in the region, has activated a purchase order for Resurgex Select following the CPR’s issuance.
Inergetics is expected to launch the product to serve as a platform for the expansion of distribution within the Association of Southeast Asian Nations (ASEAN) market, of which the Philippines is a member nation.
New Marketlink, which has distribution relationships throughout Southeast Asia, will follow its launch of Resurgex Select in the Philippines by targeting ASEAN countries like Singapore, Malaysia, Thailand, Indonesia and Vietnam as well as non-ASEAN countries such as South Korea, Taiwan and potentially China.
Mark Mirken, chairman and CEO of Inergetics, said: “We have worked hand in glove with New Marketlink and their executive team for two years to receive approval for Resurgex Select from the FDA Philippines.
“Upon our successful expansion into the ASEAN countries in 2011, this region could account for 10 to 12% of our total revenue in the coming years. Additionally, a product launch in the Asian market can create economies of scale with lower cost and manufacturing site implications for Inergetics as well.
“Now that this has been accomplished, we will launch our oncology product in the Philippines. Following our successful launch there, we plan to expand the distribution of Resurgex Select into the rest of Southeast Asia.”
Francis Wade Gomezstated, chief operating officer of New Marketlink Pharmaceutical, said: “We are very excited and pleased that a CPR has been awarded for Resurgex Select. Both New Marketlink and Inergetics have put forth a tireless and continuous effort to make this happen.